What’s CBD (cannabidiol) got to do with it?
Recent science has found that the ECS responds to both internal and external cannabinoids like CBD (cannabidiol). While both CBD and THC (tetrahydrocannabinol) both interact with CB1 and CB2 receptors throughout the body they do it using very different methods. Most people are familiar with THC and its psychoactive effects. THC does this by binding directly with the CB1 and CB2 receptors which then activates the production of anandamide “bliss” molecule which is also why people feel the “high” when taking THC. CBD works not by binding directly to the CB1 and CB2 but by stimulating the receptors and blocking the receptors in order to create an ECS response. Due to this type of interaction it has been observed that CBD will reduce the amount of THC binding with the receptors and decreasing the “bliss” or psychoactive feeling from THC.
When CBD is introduced into the ECS it activates beneficial responses from the CB1 and CB2 receptors.
Benefits of activating CB1 receptor include:
- Relieving depression
- Lowering intestinal inflammation
- Lowering blood pressure
- Lowering anxiety
- Reducing fear and paranoia
Benefits of activating CB2 receptors include:
- Lowers inflammation
- Reduces pain
- Replenish old skin cells and heals damaged ones
In addition, CBD also activates the TRPV1 Receptors which are involved in regulating pain, body temperature, and inflammation. CBD also works to inhibit Fatty Acid Amide Hydrolase (FAAH) this allows the increase in concentration of beneficial enzymes and proteins making them more available throughout the body.
In ClosingThis is just a short introduction into the major benefits of CBD and having a healthy Endocannabinoid System. Currently there are many studies being conducted to understand the full potential of CBD and other cannabinoids. We believe that we are just scratching the surface in understanding the full benefits of cannabinoids.